These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15031233)

  • 1. Benefits of implantable cardiac defibrillators in heart failure are confirmed.
    Tanne JH
    BMJ; 2004 Mar; 328(7441):664. PubMed ID: 15031233
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardiac defibrillators and cardiac resynchronization therapy for heart failure in older adults.
    Goldfinger JZ; Choi AD; Adler ED
    Geriatrics; 2009 Aug; 64(8):20-9. PubMed ID: 20722313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].
    Francia P; Cappato R
    G Ital Cardiol (Rome); 2011 May; 12(5):379-82; discussion 382. PubMed ID: 21593958
    [No Abstract]   [Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac resynchronization therapy in chronic heart failure].
    Sticherling C
    Praxis (Bern 1994); 2007 Mar; 96(11):421-2. PubMed ID: 17405535
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.
    Bunch TJ; Hohnloser SH; Gersh BJ
    Circulation; 2007 May; 115(18):2451-7. PubMed ID: 17485594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electrical treatment in heart failure].
    Leclercq C; Mabo P; Daubert C
    Rev Prat; 2010 Sep; 60(7):947-50. PubMed ID: 21033492
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up].
    Pedretti RF; Laporta A; Masnaghetti S; Raimondo R; Salerno M; Santoro F; Vaninetti R
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):134S-136S. PubMed ID: 21416844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA; Turner JW; Dec GW
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.
    Toma M; McAlister FA; Ezekowitz J; Kimber S; Gulamhusein S; Pantano A; Sivakumaran S; Cujec B; Paterson I; Armstrong PW
    Am J Cardiol; 2006 Mar; 97(6):882-5. PubMed ID: 16516594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heart failure with or without myocardial infarct. Which patient profits from defibrillator?].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219115
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indication of implantable cardioverter defibrillator for heart failure].
    Noda T; Kamakura S
    Nihon Rinsho; 2007 May; 65 Suppl 5():195-9. PubMed ID: 17571384
    [No Abstract]   [Full Text] [Related]  

  • 16. The editor's roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation.
    Friedewald VE; Fonarow GC; Olshansky B; Yancy CW; Roberts WC
    Am J Cardiol; 2011 Feb; 107(4):583-90. PubMed ID: 21295175
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called?
    Cleland JG; Nasir M; Tageldien A
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):90-101. PubMed ID: 17245403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough?
    Curtis AB
    J Am Coll Cardiol; 2008 Aug; 52(7):557-8. PubMed ID: 18687250
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter by De Ferrari and Verrier regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy".
    De Ferrari GM; Verrier RL
    Circulation; 2009 Jul; 120(3):e20; author reply e22. PubMed ID: 19620521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.